Cargando…

Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study

To characterize the immunogenicity of mRNA-1273 (Moderna, Cambridge, MA, USA) vaccine in HIV-positive hemophilic patients during the third COVID-19 wave in Italy and to investigate biomarkers of coagulation and endothelial perturbation before and after complete vaccination schedule, twenty-three con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suffritti, Chiara, Gualtierotti, Roberta, Arcudi, Sara, Ciavarella, Alessandro, Novembrino, Cristina, Lecchi, Anna, La Marca, Silvia, Padovan, Lidia, Scalambrino, Erica, Clerici, Marigrazia, Bono, Patrizia, Ceriotti, Ferruccio, Muscatello, Antonio, Siboni, Simona Maria, Peyvandi, Flora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487950/ https://www.ncbi.nlm.nih.gov/pubmed/37685542 http://dx.doi.org/10.3390/jcm12175475

Ejemplares similares

Updates on Novel Non-Replacement Drugs for Hemophilia
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
por: Capecchi, Marco, et al.
Publicado: (2023)

No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2
por: Peyvandi, Flora, et al.
Publicado: (2021)

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
por: Tripodi, Armando, et al.
Publicado: (2023)

Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy
por: La Mura, Vincenzo, et al.
Publicado: (2023)

Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
por: Bonato, Sara, et al.
Publicado: (2021)

Anti-emicizumab antibodies do not cross-react with mim8 in vitro
por: Valsecchi, Carla, et al.
Publicado: (2023)

Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19
por: Boggio, Federico, et al.
Publicado: (2022)

Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
por: Valenti, Luca, et al.
Publicado: (2022)

Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Product type and other environmental risk factors for inhibitor development in severe hemophilia A
por: Peyvandi, Flora, et al.
Publicado: (2018)

The Arrival of Gene Therapy for Patients with Hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2022)

Evaluation of procoagulant imbalance in Cushing’s syndrome after short- and long-term remission of disease
por: Ferrante, E., et al.
Publicado: (2021)

Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry
por: Indirli, Rita, et al.
Publicado: (2020)

Hemophilic arthropathy: Current knowledge and future perspectives
por: Gualtierotti, Roberta, et al.
Publicado: (2021)

Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study
por: Lombardi, Andrea, et al.
Publicado: (2021)

Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
por: Ciavarella, Alessandro, et al.
Publicado: (2020)

Hemostatic alterations in COVID-19
por: Peyvandi, Flora, et al.
Publicado: (2020)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
por: Castaman, Giancarlo, et al.
Publicado: (2023)

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review
por: Shapiro, Amy D., et al.
Publicado: (2022)

Immunogenicity of Current and New Therapies for Hemophilia A
por: Prezotti, Alessandra N. L., et al.
Publicado: (2022)

Complications of whole-exome sequencing for causal gene discovery in primary platelet secretion defects
por: Gorski, Marcin M., et al.
Publicado: (2019)

Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis
por: Artoni, Andrea, et al.
Publicado: (2017)

Thrombin Generation in Preterm Newborns With Intestinal Failure-Associated Liver Disease
por: Ghirardello, Stefano, et al.
Publicado: (2020)

Handwriting Analysis in Children and Adolescents with Hemophilia: A Pilot Study
por: Pasta, Gianluigi, et al.
Publicado: (2020)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
por: van Galen, Karin P. M., et al.
Publicado: (2021)

Hemophilia gene therapy knowledge and perceptions: Results of an international survey
por: Peyvandi, Flora, et al.
Publicado: (2020)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia
por: Boccalandro, Elena Anna, et al.
Publicado: (2023)

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database
por: Peyvandi, Flora, et al.
Publicado: (2020)

Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies
por: Dong, Ning, et al.
Publicado: (2021)

Harmonization Initiatives in Europe
por: Ceriotti, Ferruccio
Publicado: (2016)

Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
por: Panigada, Mauro, et al.
Publicado: (2020)

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
por: Anderson, Evan J., et al.
Publicado: (2020)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
por: El Sahly, Hana M, et al.
Publicado: (2022)

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1mt7fkhbao9mknmho2hh49n1s6